KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34 | -100.0% | 18,799 | -16.3% | 0.00% | -66.7% |
| Q3 2022 | $123,000 | -65.4% | 22,469 | -71.5% | 0.01% | -70.0% |
| Q2 2022 | $355,000 | -9.4% | 78,720 | +29.0% | 0.04% | -7.0% |
| Q4 2021 | $392,000 | -38.9% | 61,045 | +0.1% | 0.04% | -40.3% |
| Q1 2021 | $642,000 | +247.0% | 61,002 | +411.1% | 0.07% | +140.0% |
| Q4 2020 | $185,000 | -43.1% | 11,936 | -37.5% | 0.03% | -33.3% |
| Q3 2018 | $325,000 | +261.1% | 19,084 | +88.0% | 0.04% | +87.5% |
| Q1 2016 | $90,000 | – | 10,153 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |